Bull & Bear

Bull and Bear

Verdict: Lean Long, Wait For Confirmation - the contracted backlog and the durable database annuity are stronger, harder evidence than the bear's de-rating case, but the cash conversion that would prove them has not yet appeared, so the position earns conviction only after it does. Bull and Bear are not arguing about different companies; they are reading the same facts in opposite directions - the $638 billion RPO, the inverted free cash flow, and the five-point gross-margin step-down. The tension that matters most is whether that $638B backlog is durable, collectible revenue or concentrated counterparty credit, because every other disagreement (cash burn, margin, multiple) resolves the moment that one does. What would change the conclusion is observable and near: OCI gross margin troughing and stabilizing while operating cash flow visibly narrows the gap to capex, with no marquee-counterparty renegotiation. Until those print, the bear's risks are real enough that you wait rather than chase.

Bull Case

Bull's case rests on three pillars. First, a contracted backlog that is fact, not forecast: total remaining performance obligations finished FY2026 at $638 billion, up 363% year-over-year [1] - roughly nine times annual revenue - anchored by "the who's who of AI, including OpenAI, xAI, Meta, NVIDIA, AMD, and many others" [2]. Second, a wide-moat database annuity that underwrites the floor and funds the bet: "substantially all license support customers renew their support contracts with us upon expiration" [3], a ~$19.5 billion near-100%-margin support stream inside a 63%-margin cloud-and-license business [4], attached to "the world's most popular enterprise database" [5]. Third, proof the moat travels and pulls capital-light growth: multicloud database revenue grew 404% year-over-year and Oracle booked $75 billion of bring-your-own-hardware or prepaid contracts at no margin degradation [6].

Sources: bull points sourced as cited above - Q4 FY2026 earnings call [1] and [6]; Q1 FY2026 earnings call [2]; FY2025 Annual Report (Form 10-K) [3], [4], [5].

Bull target: $300 over 12-18 months, set at ~27x FY2028 non-GAAP EPS of ~$11 - the FY2028 consensus and consistent with management's +28% EPS CAGR off the FY2026 base, a PEG below 1 for 28% growth and between the $253 Street mean and the $400 high. The method leans on management's FY2027 guide of $8.05 non-GAAP EPS on +34% constant-currency revenue [7], the +31% revenue / +28% EPS CAGR framework through FY2030 [8], and the OCI ramp management laid out from $18B to $144B over FY2026-FY2030 [9]. Bull's disconfirming signal: a credit reserve against, or renegotiation/delay of, a marquee AI counterparty (OpenAI/Stargate), or RPO declining sequentially - any of which would expose the backlog as concentrated contract risk rather than durable revenue.

Bear Case

Bear's case rests on three pillars. First, the cash machine has inverted into a hole: FY2026 cash flow from operations of $32 billion was outstripped by $48 billion of net capital expenditure [1], with FY2027 net capex guided to ~$70 billion funded by ~$40 billion of fresh debt and equity (including a $20B at-the-market issuance) [7]. Second, the $638B backlog is concentrated counterparty credit, not a SaaS book: only 12% is expected to convert within twelve months [1], and it leans on the same cash-burning AI labs [2] who can multi-source compute. Third, capital is routed to the IaaS layer where gross margin stepped down ~5 points with a further step-down guided [1], while the reported profit is flattered by a server useful-life extension, recurring receivable factoring, and a non-GAAP EPS running ~40% above GAAP (per the report's forensic analysis).

Sources: bear points sourced as cited above - Q4 FY2026 earnings call [1] and [7]; Q1 FY2026 earnings call [2]. Forensic items (useful-life extension, factoring, GAAP-to-non-GAAP gap) are from the report's forensic analysis, not a single filing page.

Bear downside: $120 over 12-18 months, roughly 35% below the $184.29 close, set by multiple compression to ~15x forward EPS - Oracle's own pre-AI-hype historical multiple - applied to the FY2027 guided non-GAAP EPS of ~$8.05 [7]; ~15x x ~$8.05 is about $120, below the $155 analyst low and near the $138.80 the stock traded as recently as March 2026. Bear's primary trigger: a marquee AI counterparty renegotiates, delays, or wavers on funding - or a credit-rating action off investment grade as net debt climbs - forcing the sell-side to cut the out-year OCI ramp. Bear's cover signal: the FCF trajectory inflects (operating cash flow grows fast enough to visibly narrow the gap to ~$70B capex) while RPO converts to collected cash at the guided margins with no concentration crack and no further useful-life extensions.

The Real Debate

Each row below is one fact both advocates accept and read in opposite directions. The shared facts trace to the primary record: the RPO mix and the cash-flow figures to the Q4 FY2026 call [1], and the FY2027 capex and funding plan to the same call's outlook [7].

Sources: shared facts traced to the Q4 FY2026 earnings call [1] and its FY2027 outlook [7].

Verdict

The verdict is Lean Long, Wait For Confirmation, and the Bull carries more weight - but only on the strength of what is already contracted and already cash-generative, not on what is promised. The single most important tension is the first: whether the $638B RPO is durable revenue or concentrated counterparty credit, because the cash-drain and margin debates both resolve automatically once that one does. Bull wins it on evidence quality - the backlog is booked and audited rather than narrative, and beneath it sits a database annuity where "substantially all" customers renew, a genuine floor the bear consistently underweights. But the Bear could still be right, and not trivially: the cash that proves conversion has not arrived, FY2026 operating cash flow of $32B was dwarfed by $48B of capex, and the entire premium rests on out-year economics management itself frames as not-yet-proven - if a marquee counterparty's funding wobbles, Oracle owns stranded, debt-financed, depreciating capacity. The durable thesis breaker is therefore a counterparty event - a credit reserve, renegotiation, or delay at OpenAI/xAI, or a weakening of the "substantially all renew" language - which would convert this from Lean Long to Avoid. The near-term evidence marker that flips the verdict to a fuller Lean Long is narrower and observable: OCI gross margin troughing and stabilizing while operating cash flow visibly narrows the gap to the ~$70B FY2027 capex, with RPO still rising. Until that confirmation prints, the right posture is to lean long and wait, not to chase a growth multiple the company has not yet earned in cash.